Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-01-07 @ 1:41 PM
Study NCT ID:
NCT01313559
Status:
TERMINATED
Last Update Posted:
2025-04-30
First Post:
2011-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer
Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-06
Start Date Type:
None
Primary Completion Date:
2012-09-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-11-29
Completion Date Type:
ACTUAL
First Submit Date:
2011-03-10
First Submit QC Date:
None
Study First Post Date:
2011-03-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-09-08
Results First Submit QC Date:
None
Results First Post Date:
2018-01-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-28
Last Update Post Date:
2025-04-30
Last Update Post Date Type:
ACTUAL